Lidonostrum (Lidocaine)

Lidocaine blocks voltage‑gated sodium channels on nerve cells, preventing the rapid influx of sodium that initiates an action potential. By inhibiting nerve impulse conduction, the drug produces reversible loss of sensation in the area where it is applied.

The appropriate dose of Lidonostrum is determined by the prescribing healthcare professional based on the intended use, the size of the treatment area, patient age, and medical condition. Patients should follow the exact instructions provided by their clinician.

Safety data for lidocaine in pregnancy and lactation are limited. Use of Lidonostrum during pregnancy or while breastfeeding should only occur if the potential benefit justifies any potential risk to the fetus or infant, and under direct medical supervision.

To order Lidonostrum, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Lidonostrum’s lidocaine is comparable to other amide‑type local anesthetics such as prilocaine or mepivacaine in onset and duration of action. Choice among them depends on factors like required depth of anesthesia, potential for allergic reactions, and specific procedural needs.

Lidonostrum should be stored at ambient temperature, preferably below 25 °C. Keep the product in its original packaging, protect it from moisture, direct sunlight and excessive heat to maintain stability.

Lidonostrum is applied topically to the intended surface—skin, oral mucosa, nasal mucosa, or other accessible tissues. The clinician spreads a thin layer of the preparation, allowing it to absorb for the recommended contact time before proceeding with the procedure.

The most serious risks include systemic lidocaine toxicity, which can manifest as seizures, cardiac arrhythmias, or severe hypotension, and rare allergic reactions such as anaphylaxis. Prompt medical attention is required if any signs of systemic toxicity or severe hypersensitivity appear.

Lidonostrum should be avoided in individuals with known hypersensitivity to lidocaine or other amide‑type anesthetics, in patients with severe cardiac conduction disorders, and in those who have taken excessive amounts of other local anesthetics without medical guidance.